27th Oct 2020 09:36
(Alliance News) - Dechra Pharmaceuticals PLC on Tuesday told its annual general meeting that trading in the first quarter of its financial year has been "stronger then expected".
Despite the positive performance for the three months to the end of September, the FTSE 250 veterinary products firm warned that the ongoing effect of Covid-19 on the group's markets remains uncertain.
Earlier in September, Dechra said revenue for the financial year to the end of June rose by 6.9% to GBP515.1 million, while pretax profit increased by 47% to GBP40.9 million.
Dechra said it will publish its interim results on February 22, 2021.
Shares in Dechra Pharmaceuticals were down 0.2% at 3,556.00 pence on Tuesday in London.
By Dayo Laniyan; [email protected]
Copyright 2020 Alliance News Limited. All Rights Reserved.
Related Shares:
DPH.L